0
0
February 13, 2024 – In a groundbreaking discovery, researchers have found that protein biomarkers in the blood can forecast the onset of dementia up to 15 years before clinical symptoms emerge. This pivotal study, conducted by scientists from The University of Warwick and Fudan University, represents a significant leap forward in dementia research, offering hope for early detection and intervention.
The study, hailed as the most extensive of its kind, focused on blood samples from 52,645 healthy participants in the UK Biobank. Over a decade later, between April 2021 and February 2022, these preserved samples were meticulously analyzed. By March 2023, 1,417 individuals had developed dementia, with researchers pinpointing dysregulation in specific protein biomarkers as the precursor to the disease’s onset.
Through a sophisticated machine learning approach, the team scrutinized 1,463 proteins, ultimately identifying a panel of 11 proteins with remarkable accuracy in predicting future dementia cases. When combined with conventional risk factors such as age, sex, education level, and genetics, the predictive accuracy of the model soared to over 90%, offering immense potential for community-based dementia screening programs.
Lead author Professor Jianfeng Feng underscored the transformative potential of combining artificial intelligence with protein analysis, heralding a new era of precision medicine and enhanced screening for individuals at risk of dementia.
“This model could be seamlessly integrated into the NHS and used as a screening tool by GPs,” said Professor Feng.
Co-author Professor Wei Cheng highlighted the superiority of proteomic biomarkers over traditional methods, offering a non-invasive, easily accessible, and highly precise means of predicting dementia onset. Neurovegetative disease specialist Professor Jintai Yu emphasized the advantages of proteomic biomarkers, which are more easily accessible and non-invasive, facilitating large-scale population screening.
Published in the journal Nature Aging, this study not only showcases the potential of blood protein biomarkers for early dementia detection but also underscores the importance of interdisciplinary collaboration in advancing medical science. The integration of artificial intelligence, proteomics, and clinical research holds the promise of revolutionizing dementia prediction, diagnosis, and treatment, offering hope to millions affected by this devastating condition.
